XFRA NEW INSTRUMENTS AVAILABLE ON XETRA

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 09.10.2024

The following instruments on XETRA do have their first trading 09.10.2024
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.10.2024

Aktien

1 US23381D1028 Daiichi Sankyo Co. Ltd. ADR
2 KYG392AS1011 Global New Material International Holdings Ltd.
3 US4928541048 Kewaunee Scientific Corp.
4 US00439U1043 Acasti Pharma Inc.

5 BMG4R86G1074 Gold Reserve Ltd.
6 SGXZ53070850 Hafnia Ltd.
7 SGXZ57724486 Maxeon Solar Technologies Ltd.
8 US8173233060 Sequans Communications S.A. ADR

Anleihen/ETF

1 XS2914770545 Kasachstan, Republik
2 BE0002219856 FLUXYS Belgium S.A.
3 DE000BU0E220 Deutschland, Bundesrepublik
4 ES0L02510102 Spanien, Königreich
5 ES0413860877 Banco de Sabadell S.A.
6 DE000HEL0AL9 Landesbank Hessen-Thüringen Girozentrale
7 DE000HLB44Y3 Landesbank Hessen-Thüringen Girozentrale
8 DE000HLB44X5 Landesbank Hessen-Thüringen Girozentrale
9 DE000HLB44Z0 Landesbank Hessen-Thüringen Girozentrale
10 IE000GBYNAU4 AXA IM ICE US Treasury +25Y UCITS ETF
11 LU2673522830 Xtrackers II Target Maturity Sept 2027 EUR Corporate Bond UCITS ETF
12 LU2673522913 Xtrackers II Target Maturity Sept 2029 EUR Corporate Bond UCITS ETF
13 LU2673523135 Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF
14 LU2673523051 Xtrackers II Target Maturity Sept 2033 EUR Corporate Bond UCITS ETF

Zeit	Aktuelle Nachrichten
Mo	GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING
Mo	GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR
19.03.	GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING
28.02.	GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY
08.11.24	GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit

Aktuelle Nachrichten

GLOBAL NEW MAT (06616): ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 AND CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING

GLOBAL NEW MAT (06616): FURTHER DELAY IN DESPATCH OF CIRCULAR

19.03.

GLOBAL NEW MAT (06616): NOTICE OF BOARD MEETING

28.02.

GLOBAL NEW MAT (06616): RESULTS OF A SUBSIDIARY

08.11.24

GLOBAL NEW MAT (06616): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROPOSED ISSUE OF CONVERTIBLE BONDS OF UP TO US$80,000,000 UNDER GENERAL MANDATE

Zeit	Aktuelle Nachrichten
Di	Gold Reserve Ltd: Gold Reserve protests against Citgo bid recommendation
25.03.	Gold Reserve's $7.1B Bid For PDVH Not Recommended As Stalking Horse
24.03.	Camac Capital kauft Gold Reserve-Aktien im Wert von 3,68 Mio. US-Dollar
24.03.	Gold Reserve "very disheartened" multibillion dollar bid was not recommended
24.03.	Gold Reserve Ltd: Gold Reserve's $7.1B bid for Citgo not recommended

Zeit

Aktuelle Nachrichten

Gold Reserve Ltd: Gold Reserve protests against Citgo bid recommendation

25.03.

Gold Reserve's $7.1B Bid For PDVH Not Recommended As Stalking Horse

24.03.

Camac Capital kauft Gold Reserve-Aktien im Wert von 3,68 Mio. US-Dollar

24.03.

Gold Reserve "very disheartened" multibillion dollar bid was not recommended

24.03.

Gold Reserve Ltd: Gold Reserve's $7.1B bid for Citgo not recommended

Zeit	Aktuelle Nachrichten
03.03.	Grace Therapeutics, Inc. - 8-K, Current Report
19.02.	Grace Therapeutics, Inc. - 10-Q/A, Quarterly Report
18.02.	H.C. Wainwright reiterates buy on Grace Therapeutics stock
13.02.	Grace Therapeutics GAAP EPS of -$0.36 misses by $0.04
13.02.	Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update	Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half... ► Artikel lesen

Zeit

Aktuelle Nachrichten

03.03.

Grace Therapeutics, Inc. - 8-K, Current Report

19.02.

Grace Therapeutics, Inc. - 10-Q/A, Quarterly Report

18.02.

H.C. Wainwright reiterates buy on Grace Therapeutics stock

13.02.

Grace Therapeutics GAAP EPS of -$0.36 misses by $0.04

13.02.

Grace Therapeutics, Inc.: Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half...
► Artikel lesen

Zeit	Aktuelle Nachrichten
20.03.	Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market
19.03.	Hafnia Ltd - 6-K, Report of foreign issuer
19.03.	HAFNIA LIMITED: Resignation of Board Member
19.03.	HAFNIA LIMITED: Award of share options to primary insiders
18.03.	HAFNIA LIMITED: Mandatory Notification of Trade - Exercise of existing Restricted Share Units

Zeit

Aktuelle Nachrichten

20.03.

Hafnia introduces FuelSure platform to enhance transparency in bunker fuel market

19.03.

Hafnia Ltd - 6-K, Report of foreign issuer

19.03.

HAFNIA LIMITED: Resignation of Board Member

19.03.

HAFNIA LIMITED: Award of share options to primary insiders

18.03.

HAFNIA LIMITED: Mandatory Notification of Trade - Exercise of existing Restricted Share Units

Zeit	Aktuelle Nachrichten
Fr	Kewaunee Scientific CFO Donald Gardner verkauft Aktien im Wert von 120.039 US-Dollar
24.03.	Kewaunee Scientific CEO Thomas Hull verkauft Aktien im Wert von 147.228 US-Dollar
18.03.	Kewaunee Scientific-Direktor Keith Gehl erwirbt Aktien im Wert von 19.747 US-Dollar
14.03.	KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report
12.03.	Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025	STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Kewaunee Scientific CFO Donald Gardner verkauft Aktien im Wert von 120.039 US-Dollar

24.03.

Kewaunee Scientific CEO Thomas Hull verkauft Aktien im Wert von 147.228 US-Dollar

18.03.

Kewaunee Scientific-Direktor Keith Gehl erwirbt Aktien im Wert von 19.747 US-Dollar

14.03.

KEWAUNEE SCIENTIFIC CORP /DE/ - 10-Q, Quarterly Report

12.03.

Kewaunee Scientific Corporation: Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

STATESVILLE, N.C., March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
03.03.	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
18.02.	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
21.01.	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer
06.01.	Maxeon Solar Technologies, Ltd. - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten